Omeros reported $-17936000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acelrx Pharmaceuticals ACRX:US $ -8.15M 0.96M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Adma Biologics ADMA:US $ -13.02M 1.24M
Aerie Pharmaceuticals AERI:US $ -30.76M 0.92M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Gilead Sciences GILD:US $ 4370M 1605M
Insmed INSM:US $ -91545000 6.9M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Knight Therapeutics Inc GUD:CN C$ 17.02M 7.66M
Macrogenics MGNX:US $ -50191000 12.69M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Omeros OMER:US $ -17936000 5.72M
Pacira Pharmaceuticals PCRX:US $ 36.49M 3.4M
Pfizer PFE:US $ 10235M 2245M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
United Therapeutics UTHR:US $ 242.3M 7.7M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
Xoma XOMA:US $ -3343000 281K